A Sino-Indian diplomatic row has damaged out over the standard of the rapid antibody test kits exported to India by China, following their sub-par efficiency in detecting the coronavirus illness (Covid-19).
The Chinese authorities has stated criticism of the testing kits was “not based on facts” and has charged that it was “unfair and irresponsible for certain individuals to label Chinese products as ‘faulty’ and look at issues with preemptive prejudice”.
The Indian Council of Medical Research (ICMR) had on April 27 requested state governments to not use the rapid antibody test kits procured from two Chinese firms (Guangzhou Wondfo Biotech, and Zhuhai Livzon Diagnostics) and had stated these needs to be returned to the suppliers.
Reacting to the criticism, the Chinese Embassy in New Delhi —which referred to “individuals” complaining concerning the kits, not the Indian authorities —raised cudgels on behalf of the 2 personal firms.
It stated in a press release that each firms had confused that their Covid-19 rapid antibody test kits had obtained certification from the National Medical Products Administration of China (NMPA), meet the standard requirements of China and exported international locations, and had been validated and authorised by ICMR by the National Institute of Virology (NIV), Pune.
The kits produced by the corporations had been exported to and nicely recognised in many international locations in Europe, Asia, and Latin America, the assertion added.
“Any operation that is not carried out by professionals in accordance with the product specifications will lead to the testing accuracy variations. ICMR also made it clear that rapid antibody test kits should only be used for surveillance purposes instead of replacing RT-PCR test to diagnose and confirm the cases, and States are advised to strictly abide by the methods and purpose of the usage according to ICMR’s clear instructions,” the assertion stated, warning that if the kits had been used for functions they weren’t supposed to serve, the outcomes they’d present could be defective.
Explaining why it was defending two personal firms, the Chinese authorities stated many international locations had been shopping for medical tools from the Chinese markets by way of industrial channels.
“While satisfying domestic demand, we support export by companies with qualifications and credibility, and provide convenience in production, transport and Customs clearance to facilitate foreign procurement and orderly exporting to countries including India. Chinese manufacturers have been working around the clock to try their best to provide medical supplies to help other countries fight the epidemic and protect people’s lives and health,” the assertion stated. “The quality of medical products exported from China is prioritised.”
The assertion added: “we hope the Indian side could respect China’s goodwill and sincerity, strengthen communication with relevant Chinese companies based on facts, and resolve it reasonably and properly.”